Pharma Technology Focus: the dengue dilemma
In this issue: dengue fever vaccine controversy, the problem of manipulated data, fixing a broken...
Read More...
Focus:
-
![]()
‘Gene-ie in a bottle’ gene therapy opportunity is a treasure trove but CMOs lack capacity
CMOs are recognising the coming demand for gene therapies and have started to build production...
Read More...
-
![]()
Medical device and diagnostic solutions: A life cycle development model that moves your device ahead of the game
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge...
Read More...
-
![]()
How mobile health, local sample collections and virtual models are redefining where clinical trials happen
We live in an era where there is an expectation of immediate results. We connect...
Read More...
-
![]()
The importance of GMP auditing services
Good Manufacturing Practice (GMP) audits work to ensure products are made in accordance with appropriate...
Read More...
-
![]()
Deciphering real world data to accelerate clinical trials
As clinical trials get more complex and pressures to deliver increase, trial sponsors are seeking...
Read More...
-
![]()
How CMO/CDMO facilities can gain value with single use containment
That last few years have proven pivotal for contract manufacturing and development organisations (CMOs and...
Read More...
-
![]()
Pharma Technology Focus: buyers clubs in the UK
In this issue: Public attitudes towards mental health drugs, using real-world data in drug approvals,...
Read More...
-
Pharma Technology Focus: Taming big pharma
In this issue: breakthroughs in HIV treatment, understanding drug-resistant TB, the fallout from Teva’s price...
Read More...
-
![Myovant Uterine Fibroid results]()
Myovant reports uterine fibroid combination therapy results
UK healthcare company Myovant Sciences has announced positive results from LIBERTY 2, its second Phase...
Read More...
